Correlation Between Rafarma Pharmaceuticals and City View

Can any of the company-specific risk be diversified away by investing in both Rafarma Pharmaceuticals and City View at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rafarma Pharmaceuticals and City View into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rafarma Pharmaceuticals and City View Green, you can compare the effects of market volatilities on Rafarma Pharmaceuticals and City View and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rafarma Pharmaceuticals with a short position of City View. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rafarma Pharmaceuticals and City View.

Diversification Opportunities for Rafarma Pharmaceuticals and City View

0.24

Correlation Coefficient

Rafarma Pharmaceuticals  City View

Modest diversification

The 3 months correlation between Rafarma and City is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Rafarma Pharmaceuticals and City View Green in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on City View Green and Rafarma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rafarma Pharmaceuticals are associated (or correlated) with City View. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of City View Green has no effect on the direction of Rafarma Pharmaceuticals i.e., Rafarma Pharmaceuticals and City View go up and down completely randomly.

Pair Corralation between Rafarma Pharmaceuticals and City View

Given the investment horizon of 90 days Rafarma Pharmaceuticals is expected to generate 0.62 times more return on investment than City View. However, Rafarma Pharmaceuticals is 1.61 times less risky than City View. It trades about 0.15 of its potential returns per unit of risk. City View Green is currently generating about 0.07 per unit of risk. If you would invest  7.50  in Rafarma Pharmaceuticals on December 19, 2024 and sell it today you would earn a total of  6.50  from holding Rafarma Pharmaceuticals or generate 86.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.16%
Values	Daily Returns

Rafarma Pharmaceuticals  vs.  City View Green

Rafarma Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Rafarma Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent technical and fundamental indicators, Rafarma Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

City View Green

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in City View Green are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, City View reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Rafarma Pharmaceuticals and City View

The main advantage of trading using opposite Rafarma Pharmaceuticals and City View positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rafarma Pharmaceuticals position performs unexpectedly, City View can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in City View will offset losses from the drop in City View's long position.

The idea behind Rafarma Pharmaceuticals and City View Green pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.